Does losartan have potassium in it
Pro Research Analysisby 
Searched over 200M research papers
Does Losartan Contain Potassium?
Introduction to Losartan Potassium
Losartan potassium is a widely used medication primarily prescribed for the treatment of hypertension. It belongs to a class of drugs known as angiotensin II receptor antagonists, which work by blocking the effects of angiotensin II, a substance in the body that causes blood vessels to tighten and narrow, thereby lowering blood pressure1 6 9.
Composition of Losartan Potassium
Active Ingredient: Losartan Potassium
The active ingredient in this medication is losartan potassium itself. This compound is a potassium salt form of losartan, which enhances its solubility and stability, making it effective for oral administration1 4. The term "potassium" in the name refers to the potassium ion that is part of the losartan molecule, not to an additional potassium supplement.
Pharmacokinetics and Bioavailability
Losartan potassium is well-absorbed when taken orally, with a bioavailability of about 33%. It undergoes significant first-pass metabolism in the liver, where it is converted to an active metabolite, E3174, which contributes to its antihypertensive effects1. The presence of potassium in the compound does not imply that it functions as a potassium supplement.
Clinical Efficacy and Safety
Blood Pressure Management
Losartan potassium has been shown to effectively lower blood pressure in patients with mild to moderate hypertension. It is comparable in efficacy to other antihypertensive agents such as enalapril and atenolol1 7. The drug is also well-tolerated, with dizziness being the most commonly reported side effect1 8.
Combination Therapies
Losartan potassium is often combined with other medications, such as hydrochlorothiazide, to enhance its blood pressure-lowering effects. This combination has been particularly effective in patients with severe hypertension1 7.
Conclusion
Losartan potassium is an effective and well-tolerated medication for the treatment of hypertension. While it contains potassium as part of its chemical structure, it does not serve as a potassium supplement. The potassium in losartan potassium is integral to the drug's formulation and does not contribute to the body's potassium levels in a significant way. Therefore, patients taking losartan potassium do not receive additional potassium supplementation from this medication.
Sources and full results
Most relevant research papers on this topic
Losartan Potassium
Losartan potassium is a promising new antihypertensive agent with a novel mechanism of action, good efficacy, and favourable tolerability profile.
A clean photometric method for the determination of losartan potassium in pharmaceuticals exploiting light scattering effect and employing a multicommuted flow analysis approach.
This study presents a clean, environmentally friendly photometric method for determining losartan potassium in pharmaceuticals using light scattering effect and a multicommuted flow analysis approach, with a linear relationship and low waste generation.
Investigation of Losartan Potassium as an eco-friendly corrosion inhibitor for copper in 0.5 M H2SO4
Losartan Potassium (LP) effectively inhibits corrosion of copper in 0.5 M H2SO4 by forming a protective film through chemisorption, making it an eco-friendly corrosion inhibitor.
DEVELOPMENT AND EVALUATION OF PROLONGED RELEASE TRANSDERMAL PATCHES OF LOSARTAN POTASSIUM
A promising formulation containing HPMC K 15M 450 mg and ethyl cellulose 350mg effectively prolonged the release of losartan potassium for 24 hours without skin irritation.
Modulating effect of losartan potassium on the mutagenicity and recombinogenicity of doxorubicin in somatic cells of Drosophila melanogaster.
Losartan potassium does not show a mutagenic effect on Drosophila melanogaster cells, but when combined with doxorubicin, it reduces the number of mutant spots without altering the recombinogenic effect of the chemotherapeutic agent.
In Vitro StudyLosartan potassium
Losartan potassium tablets effectively lower blood pressure in adults and pediatric patients 6 years of age and older, reducing the risk of cardiovascular events.
A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension.
Losartan potassium 50 to 150 mg and enalapril maleate 20 mg both significantly reduce blood pressure in patients with mild to moderate essential hypertension, with 50 mg being essentially identical to 20 mg.
RCT
Large Human Trial
Highly CitedSafety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
Losartan potassium is an effective and well-tolerated treatment for systemic hypertension, with a better tolerability profile than other antihypertensive agents.
Highly CitedLosartan, an orally active angiotensin (AT1) receptor antagonist: a review of its efficacy and safety in essential hypertension.
Losartan potassium is an effective and safe treatment for essential hypertension, with potential benefits for elderly, liver disease, and renal impairment patients.
Literature ReviewHighly CitedEffectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome.
A combination of losartan potassium and doxycycline effectively prevents thoracic aortic aneurysm in Marfan syndrome patients, offering better secondary prevention than single-drug treatments.
Non-RCT
Animal StudyHighly Cited